High Outlier
Strength
25 mg/5mL
Manufacturer
Padagis US LLCNDC
00574113304
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
SPIRONOLACTONEApproval Type
Authorized Generic (NDA)
FDA Application
NDA209478On Market Since
10/31/2023
Pharmacological Classes
Aldosterone Antagonist
Aldosterone Antagonists
Related Drugs
Same classification
SPIRONOLACTONE 25 MG TABLET
Generic
53489014301•Sun Pharmaceutical Industries Inc.
$0.0450
per EA
SPIRONOLACTONE 25 MG TABLET
Generic
53489014305•Sun Pharmaceutical Industries Inc.
$0.0450
per EA
SPIRONOLACTONE 25 MG TABLET
Generic
53489014310•Sun Pharmaceutical Industries Inc.
$0.0450
per EA
SPIRONOLACTONE 25 MG TABLET
Generic
53746051101•Amneal Pharmaceuticals of New York LLC
$0.0450
per EA
SPIRONOLACTONE 25 MG TABLET
Generic
53746051105•Amneal Pharmaceuticals of New York LLC
$0.0450
per EA
SPIRONOLACTONE 25 MG TABLET
Generic
53746051110•Amneal Pharmaceuticals of New York LLC
$0.0450
per EA
SPIRONOLACTONE 25 MG TABLET
Generic
59651042601•Aurobindo Pharma Limited
$0.0450
per EA
SPIRONOLACTONE 25 MG TABLET
Generic
59651042605•Aurobindo Pharma Limited
$0.0450
per EA
SPIRONOLACTONE 25 MG TABLET
Generic
59651042699•Aurobindo Pharma Limited
$0.0450
per EA
SPIRONOLACTONE 25 MG TABLET
Generic
60687046501•American Health Packaging
$0.0450
per EA